Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2018, Article ID 7236452, 4 pages
https://doi.org/10.1155/2018/7236452
Case Report

Diabetes Mellitus with Poor Glycemic Control as a Consequence of Inappropriate Injection Technique

1Hospital Pharmacy, Chitwan Medical College Teaching Hospital, Chitwan, Nepal
2Department of Pharmacy, Shree Medical and Technical College, Chitwan, Nepal
3Department of Internal Medicine, Chitwan Medical College Teaching Hospital, Chitwan, Nepal

Correspondence should be addressed to Ramesh Sharma Poudel; pn.ude.cmc@hsemar.leduop

Received 13 January 2018; Revised 16 February 2018; Accepted 25 February 2018; Published 1 April 2018

Academic Editor: John Broom

Copyright © 2018 Ramesh Sharma Poudel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. C. Lee, S. Balu, D. Cobden, A. V. Joshi, and C. L. Pashos, “Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data,” Clinical Therapeutics, vol. 28, no. 10, pp. 1712–1725, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Ahmann, S. L. Szeinbach, J. Gill, L. Traylor, and S. K. Garg, “Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes,” Diabetes Technology & Therapeutics, vol. 16, no. 2, pp. 76–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Brunton, “Initiating insulin therapy in type 2 diabetes: Benefits of insulin analogs and insulin pens,” Diabetes Technology & Therapeutics, vol. 10, no. 4, pp. 247–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Thurman, “Insulin pen injection devices for management of patients with type 2 diabetes: Considerations based on an endocrinologist's practical experience in the United States,” Endocrine Practice, vol. 13, no. 6, pp. 672–678, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Grassi, P. Scuntero, R. Trepiccioni, F. Marubbi, and K. Strauss, “Optimizing insulin injection technique and its effect on blood glucose control,” Journal of Clinical & Translational Endocrinology, vol. 1, no. 4, pp. 145–150, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Frid, L. J. Hirsch, A. R. Menchior, D. R. Morel, and K. W. Strauss, “Worldwide injection technique questionnaire study: population parameters and injection practices,” Mayo Clinic Proceedings, vol. 91, no. 9, pp. 1212–1223, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Karges, B. O. Boehm, and W. Karges, “Early hypoglycaemia after accidental intramuscular injection of insulin glargine,” Diabetic Medicine, vol. 22, no. 10, pp. 1444-1445, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. P. Chakraborty, S. N. Biswas, and S. Patra, “Faulty injection technique: a preventable but often overlooked factor in insulin allergy,” Diabetes Therapy, vol. 7, no. 1, pp. 163–167, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Sanyal, S. Ghosh, S. Chowdhury, and S. Mukherjee, “Can a faulty injection technique lead to a localized insulin allergy?” Indian Journal of Endocrinology and Metabolism, vol. 17, no. 1, pp. S358–S359, 2013. View at Publisher · View at Google Scholar
  10. A. Frid, L. Hirsch, R. Gaspar et al., “The third injection technique workshop in athens (TITAN),” Diabetes & Metabolism, vol. 36, no. 2, pp. S19–S29, 2010. View at Google Scholar
  11. A. H. Frid, G. Kreugel, G. Grassi et al., “New insulin delivery recommendations,” Mayo Clinic Proceedings, vol. 91, no. 9, pp. 1231–1255, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Shrestha and R. Bhandari, “Insight into human resources for health status,” Health Prospect, vol. 11, pp. 40–44, 2013. View at Publisher · View at Google Scholar
  13. J. Moshang, “Getting the job done: The diabetes nurse specialist,” International Journal of Clinical Practice, vol. 61, no. 9, pp. 1429–1431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. B. K. Poudel and I. Ishii, “Hospital pharmacy service in developing nations: the case of Nepal,” Research in Social & Administrative Pharmacy, vol. 12, no. 6, pp. 1038-1039, 2016. View at Publisher · View at Google Scholar
  15. R. S. Poudel and A. Prajapati, “Hospital pharmacy profession in Nepal through the eye of a pharmacist,” Journal of Chitwan Medical College, vol. 6, no. 16, pp. 56-57, 2017. View at Publisher · View at Google Scholar
  16. S. Gyawali, D. S. Rathore, K. Adhikari, P. R. Shankar, V. K. Kc, and S. Basnet, “Pharmacy practice and injection use in community pharmacies in Pokhara city, Western Nepal,” BMC Health Services Research, vol. 14, p. 190, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Shrestha, R. Maharjan, A. Prajapati, S. Ghimire, N. Shrestha, and A. Banstola, “Assessment of knowledge and practice of community pharmacy personnel on diabetes mellitus management in Kathmandu district: A cross sectional descriptive study,” Journal of Diabetes and Metabolic Disorders, vol. 14, no. 1, article no. 71, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. M. D. Bhattarai, “Comprehensive diabetes and non-communicable disease educator in the low-resource settings,” Journal of Nepal Medical Association, vol. 54, no. 202, pp. 94–103, 2016. View at Google Scholar · View at Scopus